CSIMarket Company Name, Ticker, Customers, else..
 
Electromed Inc   (ELMD)
Other Ticker:  
 
 
Price: $18.2300 $0.00 0.000%
Day's High: $18.91 Week Perf: 1.9 %
Day's Low: $ 17.90 30 Day Perf: 28.11 %
Volume (M): 62 52 Wk High: $ 18.91
Volume (M$): $ 1,138 52 Wk Avg: $13.46
Open: $18.20 52 Wk Low: $9.53



 Market Capitalization (Millions $) 162
 Shares Outstanding (Millions) 9
 Employees -
 Revenues (TTM) (Millions $) 55
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) 9
 Capital Exp. (TTM) (Millions $) 0

Electromed Inc
Electromed Inc is a medical device company that specializes in the design, manufacture, and distribution of airway clearance systems for patients with respiratory conditions. These systems help to clear mucus and other secretions from the airways, improving respiratory function and overall lung health. Electromed's flagship product is the SmartVest Airway Clearance System, which utilizes high-frequency chest wall oscillation technology to mobilize and remove mucus from the lungs. The company also provides clinical support and education to healthcare professionals and patients. Electromed Inc is committed to improving the quality of life for individuals with respiratory conditions through innovative and effective medical solutions.


   Company Address: 500 Sixth Avenue NW New Prague 56071 MN
   Company Phone Number: 758-9299   Stock Exchange / Ticker: NYSEAMER ELMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Electromed Inc

2. Electromed Inc Posts Impressive Financial Results During Third Quarter of 2024 Earnings Season

Electromed Inc, a leading player in the Medical Equipment & Supplies industry, recently reported impressive financial results for the third quarter of 2024. The company's profit per share surged by 41.67% to $0.17 per share, while revenue increased by 14.94% to $13.87 million compared to the prior year period. These results outpaced industry peers, who only saw a 6.11% revenue growth during the same period.
This strong performance is a testament to Electromed Inc's solid efficiency and market additions. The company's net earnings also saw a significant increase, rising by 38.88% to $1.493 million. Electromed Inc also highlighted its improving profit margins, with net margin rising to 10.76% and operating margin increasing to 13.27%. Operating earnings saw a notable increase of 53.93% to $1.841 million.
Electromed Inc

Electromed Inc Skyrockets with a Striking 72.73% Surge in Income during 2023 Fiscal Year

Electromed Inc, a leading player in the medical equipment and supplies industry, has displayed impressive financial numbers in its most recent fiscal period. The company reported a revenue of $13.69 million, showing a 16.711% increase year on year and an 11.076% increase quarter on quarter. This growth in revenue is particularly notable given that the Medical Equipment & Supplies sector as a whole only saw an average revenue increase of 4.08% during the same period.
One of the key highlights of Electromed Inc's financial performance is the significant improvement in earnings per share, which increased by 72.73% to $0.19. Sequentially, earnings per share saw a remarkable increase of 850%, indicating a strong upward trend in profitability. The company also reported a net income of $1.674 million, representing a 71.34% increase from the previous year.
Electromed Inc

Electromed Inc. Shines in Double-Digit Revenue Surge, Fueling Optimism for Future Growth



Electromed Inc, a leading Medical Equipment & Supplies company, recently released its financial results for the fiscal interval ending September 30, 2023. The company displayed a solid performance, with notable improvements in revenue, net profits, and profit margins. However, a decline in earnings per share and an increase in inventories raise questions about the company's future growth prospects.
Positive Revenue Growth:
Electromed Inc reported a 15.631% year-on-year increase in revenue, reaching $12.32 million in the fiscal interval closing September 30, 2023. This growth compares favorably to the stagnant 4.03% top-line advance observed in the Medical Equipment & Supplies industry. The company's ability to outperform its industry peers in revenue generation suggests a strong market position and favorable business prospects.
Electromed Inc

Electromed Inc Bounces Back: Impressive Q2 Results Show 169.71% Surge in Earnings and 20.792% Revenue Growth

Investors may be concerned about the recent performance of Electromed Inc (ELMD) shares, as they have experienced a decline of -4.24% over the past five days. This negative trend has contributed to a year-to-date performance of -9.13%. Furthermore, the company's shares have reached their 52-week low.
However, it is important to note that Electromed Inc exhibited a respectable advance in the April to June 2023 three months. During this period, the company's earnings per share saw a significant year-on-year increase of 169.71% to $0.12 per share. Additionally, revenue showed growth of 20.792% to $13.61 million.
Electromed Inc

Electromed Inc Achieves Phenomenal 71.43% Income Surge, Setting New Industry Benchmark in Medical Equipment & Supplies

Electromed Inc is a company that specializes in the development and commercialization of innovative medical technologies that enhance the respiratory care of patients with chronic respiratory conditions. The company has been in operation for over three decades, and in that time, it has established itself as one of the leading players in the medical equipment and supplies sector.
In the most recent fiscal period, Electromed Inc delivered impressive results, with revenue reaching $12.07 million. This represented an increase of 19.002% year on year and growth of 2.89% quarter on quarter. The company's income per share also experienced a significant increase of 71.43%, reaching $0.12, whereas sequentially, income improved by 9.09%.






Electromed Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com